TrialBritish journal of pharmacology1996

The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.

C Plumpton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.